Annals of Pharmacotherapy
The American Heart Association recently published an updated scientific statement on the management of infective endocarditis in childhood. The recommendations included for vancomycin, aminoglycoside, and β-lactam dosing and monitoring are based primarily on expert opinion and do not consider available evidence for dose optimization based on pharmacokinetic and pharmacodynamic principles in pediatric patients. This is concerning because even when clinically necessary, some practitioners may be hesitant to deviate from guideline-recommended doses. In this perspective, we highlight potential areas for improvement in the statement-recommended doses and summarize evidence supporting antibiotic dosing optimization. The addition of a pediatric clinical pharmacist with expertise in antibiotic dosing to the panel would be beneficial for future updates.
This is a post-print version of an article originally published in Annals of Pharmacotherapy,2016, Volume 50, Issue 5.
The version of record is available through: SAGE.
Knoderer, Chad A.; Nichols, Kristen R.; Israel, Emily N.; and Thomas, Christopher A., "Optimizing Guideline-Recommended Antibiotic Doses for Pediatric Infective Endocarditis" (2016). Scholarship and Professional Work – COPHS. 243.